GENERALACTIVE
5 hours ago · United States
US FDA rejects closely watched lung cancer drug from China
SIGNALSMONITORGENERAL
What's happening
SignalsMonitor is following this as a general story. The Straits Times World and New York Times Business are the outlets attached to this story. The reports are tied to United States. The first report grouped here was at 15 Nov 2026, 20:33 UTC. 2 material updates are listed in the timeline. The headline in use is “US FDA rejects closely watched lung cancer drug from China”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
The Straits Times WorldRead at The Straits Times World
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by New York Times Business
- Picked up by The Straits Times World
Same story, different outlets
2 headlinesEach line is that outlet's headline. The article stays on the publisher's site.
- The Straits TimesUS FDA rejects closely watched lung cancer drug from China
- The New York TimesF.D.A. Rejects Closely Watched Lung Cancer Drug From China